Wilmington, Delaware, United States, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - Recent insights on the diagnostic imaging services market indicate that the need for increased accuracy of diagnosis of various medical conditions has led medtech companies to make continuous technological advancements in medical imaging equipment. Commercialization of computed tomography (CT) modalities has boosted sales of diagnostic imaging services market. The market value of the diagnostic imaging services is forecast to cross US$ 544.7 Bn by the end of 2031.

Medical device companies in diagnostic imaging services market are increasingly integrating advanced technologies such as artificial intelligence and 3D imaging in new product developments to bolster the comfort and diagnostic accuracy. Stridently, advancements in computer vision systems and increasing trend of hardware miniaturization in imaging devices have unlocked new revenue streams. Cutting-edge technologies that increase the reliability of measurements particularly in oncology will drive expansion of the diagnostic imaging services market in next few years.

Most players apart from launching new technologies are also leaning on making them affordable to patients at large. Diagnostic centers are expected to rapidly adopt diagnostic radiography over the next few years. Rise in demand for multi-modal diagnostics imaging devices is catalyzing the growth prospects of the segment.

Get Exclusive PDF Sample Copy of Diagnostic Imaging Services Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=35717

Key Findings of Diagnostic Imaging Services Market Study

Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=35717

Diagnostic Imaging Services Market: Key Drivers

Diagnostic Imaging Services Market: Regional Growth Dynamics

Make an Enquiry Before Buyinghttps://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=35717

Diagnostic Imaging Services Market: Key Players

The TMR study finds that the competition landscape is highly consolidated with only few service providers holding significant stakes in the market. Top players are leaning on launching cutting-edge diagnostic imaging modalities to grow their shares and consolidate their positions. Stridently, firms are keenly undertaking partnerships and joint ventures to grow their patient base.

Some of the key players in diagnostic imaging services market are Dignity Health, Shimadzu Corporation, GE Healthcare, Koninklijke Philips N.V., Carestream Health, Hitachi, Ltd., Siemens Healthineers, Siemens Healthineers, Center for Diagnostic Imaging (CDI), and RadNet, Inc.

Diagnostic Imaging Services Market Segmentation

Regions

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:

Cervical Cancer Diagnostic Tests Market: The global cervical cancer diagnostic tests market is expected to exceed value of US$ 13.6 Bn by the end of 2031 with a CAGR of 4.6% from 2022 to 2031.

Central Lab Market: The global central lab market is expected to reach the value of US$ 4 Bn by the end of 2031 with a CAGR of 5.4% from 2021 to 2031.

In Vitro Diagnostics Market: The global in vitro diagnostics market is expected to reach the value of US$ 115.43 Bn by the end of 2028 with a CAGR of 6.3% from 2021 to 2028.

ASRs and RUOs Market: The U.S. ASRs and RUOs market is expected to surpass the value of US$ 5.3 Bn by the end of 2031 with a CAGR of 4.7% from 2021 to 2031.

Companion Diagnostics Market: The global companion diagnostics market is expected to reach the value of US$ 9.30 Bn by the end of 2028 with a CAGR of 9% from 2021 to 2028.

Bioprocess Technology Market: The global bioprocess technology market is expected to reach the value of US$ 53.7 Bn by the end of 2031 with a CAGR of 8.3% from 2021 to 2031.

Animal Genetics Market: The global animal genetics market is anticipated to reach more than US$ 9.1 Bn by the end of 2031 with a CAGR of 6.7% from 2022 to 2031.

Ketoanalogue for Kidney Disease Market: Global ketoanalogue for kidney disease market stood at US$ 214.7 Mn. The global market is anticipated to rise at a CAGR of 6.5% during the forecast period, from 2022 to 2031.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Websitehttps://www.transparencymarketresearch.com
Bloghttps://tmrblog.com
Email: sales@transparencymarketresearch.com